Ad

MBX – Microbix Biosystems Inc

Compliant

★★★☆☆

Microbix Biosystems Inc is Shariah compliant. The company’s financials pass three standards and fail in two.

$53,591,761

Market cap

53.88%

Revenue Growth

BUY

Analysts' Rating

Ad

Recommendation Rating

2

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 0.97

Low: 0.97

High: 0.97

Total Analysts: 1

Company Profile

Microbix Biosystems Inc. is a Canada-based company, which develops and commercializes biological and technology solutions. The Company manufactures a range of biological materials for the diagnostics industry, notably antigens (Antigen business) used in immunoassays and its quality assessment and proficiency testing controls (QAPs business). The Company operates in two segments: the development, manufacturing, and sales of antigens as materials for the medical diagnostic industry or as quality assessment products (as finished products) and viral transport medium (VTM) and the development and commercialization of products or technologies such as Kinlytic and . The Kinlyti urokinase, which is a biologic thrombolytic drug used to treat blood clots. The Company’s catalogue of catalogue covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually transmitted and insect-borne diseases. Its QAPs are available in over 30 countries.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses